Directorate Change

TruSpine Technologies PLC

14 June 2023

 

14 June 2023

TruSpine Technologies plc

("TruSpine" or the "Company")

Directorate change

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that the Company has terminated its letter of appointment agreement with Annabel Schild, Independent Non-Executive Director of the Company, with immediate effect and Ms. Schild has been removed as a director of the Company with immediate effect.

This announcement contains inside information for the purposes of the UK Market Abuse Regulation, and the Directors of the Company are responsible for the release of this announcement.

Enquiries:

TruSpine Technologies Plc	Tel: [phone]
Laurence Strauss, Chief Executive Officer
Cairn Financial Advisers LLP (AQSE Corporate Adviser)	Tel: [phone]
Liam Murray / Ludovico Lazzaretti
Oberon Capital (Joint Broker)	Tel: [phone]
Mike Seabrook / Chris Crawford
Peterhouse Capital Limited (Joint Broker & Financial Adviser)	Tel: [phone]
Lucy Williams / Duncan Vasey
Novus Communications (PR and IR)	Tel: [phone]
Alan Green / Jacqueline Briscoe	[e-mail]

 

END